loader
Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Sugammadex

Client Email Product
Filters Filter
×
FILTER DATA :

filter

SUGAMMADEX SODIUM

filter

6949527

7265099

RE44733

filter

Y

Blank

filter

Y

Blank

filter

2020-08-07

2021-01-27

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

7265099
2020-08-07
U-1795
22225
REVERSAL OF NEUROMUSCLUAR BLOCKAGE INDUCED BY ROCURONIUM BROMIDE OR VECURONIUM BROMIDE
1

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

6949527
2021-01-27
U-1795
22225
REVERSAL OF NEUROMUSCLUAR BLOCKAGE INDUCED BY ROCURONIUM BROMIDE OR VECURONIUM BROMIDE
1

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

RE44733
Y
Y
2021-01-27
U-1794
22225
REVERSAL OF DRUG-INDUCED NEUROMUSCLUAR BLOCK
1

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

RE44733
Y
Y
2021-01-27
U-1794
22225
REVERSAL OF DRUG-INDUCED NEUROMUSCLUAR BLOCK
2

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

7265099
2020-08-07
U-1795
22225
REVERSAL OF NEUROMUSCLUAR BLOCKAGE INDUCED BY ROCURONIUM BROMIDE OR VECURONIUM BROMIDE
2

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

6949527
2021-01-27
U-1795
22225
REVERSAL OF NEUROMUSCLUAR BLOCKAGE INDUCED BY ROCURONIUM BROMIDE OR VECURONIUM BROMIDE
2

PharmaCompass >>

First
Previous
Next
Last